drugset / Trial / NCT00445315
A Phase 1 Study Of PF-00868554 In Hepatitis C Virus (HCV) Positive Patients
RandomizedSingle-groupDouble-blindTreatment
Summary
Assess the safety, tolerability and pharmacokinetics of multiple oral doses of PF-00868554 in HCV positive patient volunteers
Timeline
- Start
- 2007-01
- Primary completion
- 2008-06
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Filibuvir | Small molecule | 100 mg | Oral |
| Subject | Filibuvir | Small molecule | 300 mg | Oral |
| Subject | Filibuvir | Small molecule | 450 mg | Oral |